As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...

Granules India’s shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing ...

Granules added that manufacturing and distribution of its existing products at the facility will continue unaffected.

"On February 26, 2025, the US FDA issued a Warning Letter to Granules' Gagillapur facility based on its inspection conducted ...

The Warning Letter is dated February 26, 2025 and the facility continues to hold an "Official Action Indicated" (OAI) status.

The USFDA issued a warning letter to Granules India Ltd's Gagillapur facility after an August 2024 inspection highlighted ...

Granules India's Gagillapur facility receives FDA warning letter, impacting product submissions review until resolved, company remains confident in resolution.

The development may temporarily delay the approval of pending product submissions from the site, but existing manufacturing ...

Drug firm Granules India Ltd on Thursday (February 27) announced that the US FDA has issued a Warning Letter for its ...

The combined organization represents operators across 38 states and a substantial amount of the 13,000 retail locations and ...

Seeing the words "Class I food recall" might make you think of contaminated products sitting on grocery store shelves, but ...

The island’s unique position has not only made it a focal point for military operations, but also a significant site for understanding the patterns of drug use among U.S. veterans. This letter ...